Peroxisome proliferator-activated receptor γ prevents the production of NOD-like receptor family, pyrin domain containing 3 inflammasome and interleukin 1β in HK-2 renal tubular epithelial cells stimulated by monosodium urate crystals

被引:23
|
作者
Hong, Wei [1 ]
Hu, Shasha [2 ]
Zou, Jianan [2 ]
Xiao, Jing [2 ]
Zhang, Xiaoli [2 ]
Fu, Chensheng [2 ]
Feng, Xinhui [2 ]
Ye, Zhibin [2 ]
机构
[1] Fudan Univ, Huadong Hosp, Dept Geriatr, Shanghai 200040, Peoples R China
[2] Fudan Univ, Huadong Hosp, Dept Nephrol, Shanghai 200040, Peoples R China
关键词
peroxisome proliferator-activated receptor gamma; monosodium urate crystals; renal tubular epithelial cells; interleukin; 1; beta; NALP3; inflammasome; pioglitazone; ISCHEMIA-REPERFUSION INJURY; NALP3; INFLAMMASOME; EXPRESSION; AGONIST; GOUT; RATS; ROSIGLITAZONE; HYPERURICEMIA; PIOGLITAZONE; INDUCTION;
D O I
10.3892/mmr.2015.4145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent evidence showed that peroxisome proliferator-activated receptor gamma (PPAR gamma) ameliorates a variety of inflammatory conditions. The present study aimed to investigate the role of PPAR gamma in regulating NOD-like receptor family, pyrin domain containing 3 (NALP3) inflammasome and interleukin (IL)-1 beta levels during monosodium urate (MSU) crystal-induced inflammation. HK-2 cells were incubated with or without 200 mu g/ml MSU crystals, and mRNA and protein levels of PPAR gamma were determined using reverse transcription quantitative polymerase chain reaction and western blot analysis, respectively. To verify the role of PPAR gamma, HK-2 cells were pre-treated with PPAR gamma agonist pioglitazone, and the levels of NALP3 inflammasome and IL-1 beta were detected by western blot analysis and ELISA. The results showed that MSU crystals increased PPAR gamma expression in HK-2 cells at 24 h, while the expression decreased to normal levels at 48 h. It was also demonstrated that although the PPAR gamma agonist pioglitazone did not alter the mRNA and protein levels of PPAR gamma, it significantly reduced the MSU crystal-induced production of NALP3 inflammasome and IL-1 beta in HK-2 cells, possibly by increasing the level of PPAR gamma activity. In conclusion, the results of the present study indicated that PPAR gamma prevented NALP3 inflammasome formation and IL-1 beta production in HK-2 cells stimulated by MSU crystals, which indicated that PPAR gamma may represent a novel target for the treatment of hyperuricemic nephropathy.
引用
收藏
页码:6221 / 6226
页数:6
相关论文
共 12 条
  • [1] Small molecule inhibitor binds to NOD-like receptor family pyrin domain containing 3 and prevents inflammasome activation
    Lackner, Angela
    Cabral, Julia Elise
    Qiu, Yanfei
    Zhou, Haitian
    Leonidas, Lemuel
    Pham, Minh Anh
    Macapagal, Alijah
    Lin, Sophia
    Armanus, Emy
    McNulty, Reginald
    ISCIENCE, 2024, 27 (08)
  • [2] The Emerging Role of Colchicine to Inhibit NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome and Interleukin-1β Expression in In Vitro Models
    Astiawati, Tri
    Rohman, Mohammad Saifur
    Wihastuti, Titin
    Sujuti, Hidayat
    Endharti, Agustina
    Sargowo, Djanggan
    Oceandy, Delvac
    Lestari, Bayu
    Triastuti, Efta
    Nugraha, Ricardo Adrian
    BIOMOLECULES, 2025, 15 (03)
  • [3] Tacrolimus prevents complement-mediated Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation and pyroptosis of mesenchymal stem cells from immune thrombocytopenia
    Cai, Xuan
    Wu, Jin
    An, Zhuo-Yu
    Wang, Chen-Cong
    Zhu, Xiao-Lu
    He, Yun
    Fu, Hai-Xia
    Huang, Xiao-Jun
    Zhang, Xiao-Hui
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, : 995 - 1010
  • [4] NOD-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Activation Exacerbates 5-Fluorouracil-Induced Small Intestinal Mucositis via Interleukin-1β Activation
    Nakata, Akinobu
    Nadatani, Yuji
    Watanabe, Toshio
    Matsumoto, Yuji
    Kosaka, Satoshi
    Higashimori, Akira
    Otani, Koji
    Hosomi, Shuhei
    Tanaka, Fumio
    Kamata, Noriko
    Taira, Koichi
    Nagami, Yasuaki
    Tanigawa, Tetsuya
    Fujiwara, Yasuhiro
    DIGESTION, 2021, 102 (02) : 298 - 312
  • [5] Expression and correlation of the NOD-like receptor family, pyrin domain-containing 3 inflammasome and the silent information regulator 1 in patients with drug-resistant epilepsy
    Li, Qing
    Qu, Zhenzhen
    Jia, Lijing
    Wang, Weiping
    EPILEPSY RESEARCH, 2024, 201
  • [6] Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice
    Cheng, Yinzhi
    Li, Shuai
    Wang, Muzi
    Cheng, Cheng
    Liu, Rongyu
    MEDICAL SCIENCE MONITOR, 2018, 24 : 9045 - 9053
  • [7] HMG-CoA Reductase Inhibitors Suppress Monosodium Urate-Induced NLRP3 Inflammasome Activation through Peroxisome Proliferator-Activated Receptor-γ Activation in THP-1 Cells
    Kim, Seong-Kyu
    Choe, Jung-Yoon
    Kim, Ji-Won
    Park, Ki-Yeun
    PHARMACEUTICALS, 2023, 16 (04)
  • [8] Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway
    Yin, Yanlin
    Zhou, Zhihui
    Liu, Weiwei
    Chang, Qun
    Sun, Guanqun
    Dai, Yalei
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2017, 84 : 22 - 34
  • [9] Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod-like receptor family pyrin domain-containing 3/caspase-1/Gasdermin E mediated pyroptosis pathway
    Xu, Peng-peng
    Wu, Jie
    Zhang, Jing
    Yu, Tian-yue
    Wang, Yu-bin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
  • [10] Inflammasome components caspase-1, IL1β, IL18 and NLRP3 (NOD-like receptor family, pyrin domain containing 3) are increased in a spontaneous model (chicken: Gallus gallus) of human ovarian cancer
    Luborsky, Judith
    Edassery, Seara
    Edassery, Seby L.
    Barua, Animesh
    Bahr, Janice M.
    CANCER RESEARCH, 2016, 76